Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease.

Autor:	Kalla, Rahul, Adams, Alex T., Bergemalm, Daniel, Vatn, Simen Svendsen, Kennedy, Nicholas A., Ricanek, Petr, Lindstrøm, Jonas Christoffer, Ocklind, Anette, Hjelm, Fredrik, Ventham, Nicholas T., Ho, Gwo-Tzer, Petren, C., Repsilber, Dirk, Söderholm, Johan D., Pierik, Marieke J., Amato, M., Gomollón, Fernando, Olbjørn, Christine, Jahnsen, Jørgen, Vatn, Morten H, Halfvarson, Jonas, Satsangi, Jack
Zdroj:	Kalla, Rahul Adams, Alex T. Bergemalm, Daniel Vatn, Simen Svendsen Kennedy, Nicholas A. Ricanek, Petr Lindstrøm, Jonas Christoffer Ocklind, Anette Hjelm, Fredrik Ventham, Nicholas T. Ho, Gwo-Tzer Petren, C. Repsilber, Dirk Söderholm, Johan D. Pierik, Marieke J. Amato, M. Gomollón, Fernando Olbjørn, Christine Jahnsen, Jørgen Vatn, Morten H Halfvarson, Jonas Satsangi, Jack . Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease.. Jo Jo
Databáze:	NORA (Norwegian Open Research Archive)
Externí odkaz:	http://hdl.handle.net/10852/84957 https://www.duo.uio.no/bitstream/handle/10852/84957/2/jjaa230.pdf Zobrazit plný text záznamu